DRUG
Bright Minds Biosciences Inc.NASDAQHealthcare$71.46+4.93%ClosedMarket Cap: $554.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
9.05
P/S
0.00
EV/EBITDA
-37.58
DCF Value
$8.50
FCF Yield
-1.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-28.5%
ROA
-21.8%
ROIC
-21.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $0.00 | NaN% | $-6.9M | $-7.6M | $-0.97 | — |
| Q4 2025 | $0.00 | NaN% | $-5.7M | $-4.1M | $-0.41 | — |
| FY 2025 | $0.00 | NaN% | $-13.9M | $-12.2M | $-1.78 | — |
| Q3 2025 | $0.00 | NaN% | $-3.3M | $-5.2M | $-0.74 | — |
| Q2 2025 | $0.00 | NaN% | $-3.4M | $-3.0M | $-0.63 | — |
| Q1 2025 | $0.00 | NaN% | $-1.6M | $49.6K | $0.01 | — |
| Q4 2024 | $0.00 | NaN% | $-791.3K | $-773.4K | $-0.17 | — |
| FY 2024 | $0.00 | NaN% | $-2.8M | $-2.8M | $-0.65 | — |
| Q3 2024 | $0.00 | NaN% | $234.7K | $229.9K | $0.05 | — |
| Q2 2024 | $0.00 | NaN% | $-558.1K | $-574.1K | $-0.13 | — |
| Q1 2024 | $0.00 | NaN% | $-1.7M | $-1.7M | $-0.44 | — |
| Q4 2023 | $0.00 | NaN% | $-1.6M | $-1.5M | $-0.41 | — |